CCK-8 assays revealed that the proliferation of AML cells transfected with pcDNA3.1 SUCLG2-AS1 was significantly decreased compared to that of the pcDNA3.1 Vector group (Fig. 5B). This evidence concerns the gene SUCLG2 and acute myeloid leukemia.